Current Report Filing (8-k)
July 21 2021 - 8:35AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (Date of Earliest Event Reported): July 21, 2021
TRxADE
HEALTH, INC.
(Exact
name of Registrant as specified in its charter)
Delaware
|
|
001-39199
|
|
46-3673928
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
3840
Land O’ Lakes Blvd
Land
O’ Lakes, Florida 34639
(Address
of principal executive offices) (zip code)
Registrant’s
telephone number, including area code: 800-261-0281
Trxade
Group, Inc.
(Former
name or former address, if changed since last report.)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Common
Stock,
$0.00001
Par Value Per Share
|
|
MEDS
|
|
The
NASDAQ Stock Market LLC
(Nasdaq
Capital Market)
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [X]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
8.01 Other Events.
On
July 21, 2021, TRxADE HEALTH, INC. (“Trxade” or the “Company”) issued a press release announcing
that Bonum Health, a Digital Healthcare business subsidiary has signed a Telemedicine Service Distribution Deal with Southeastern Grocers
Inc., parent company of Winn-Dixie, Harveys Supermarket and Fresco y Más grocery stores throughout the five states of Florida,
Alabama, Louisiana, Georgia and Mississippi.
A
copy of the press release is attached hereto as Exhibit
99.1 and is incorporated herein by reference.
This
Item 8.01 and Exhibit 99.1 hereto contains certain statements that may be deemed to be “forward-looking statements”
within the safe harbor provisions under The Private Securities Litigation Reform Act of 1995 (the “Act”). You can
identify these forward-looking statements by words such as “may,” “should,” “expect,”
“anticipate,” “believe,” “estimate,” “intend,” “plan”
and other similar expressions. Forward-looking statements are not a guarantee of performance and are subject to a number of risks and
uncertainties, many of which are difficult to predict and are beyond our control. These risks and uncertainties should be carefully considered.
We caution you not to place undue reliance on the forward-looking statements, which involve known and unknown risks, uncertainties and
other factors, which may cause the results of the Company, its divisions and concepts to be materially different than those expressed
or implied in such statements. These risk factors and others are included from time to time in documents the Company files with the Securities
and Exchange Commission, including but not limited to, its Form 10-Ks, Form 10-Qs and Form 8-Ks. The forward-looking statements contained
in this Item 8.01 and Exhibit 99.1 are made as of the date hereof. We disclaim any obligation to update any of these forward-looking
statements as a result of new information, future events, or otherwise, except as expressly required by law.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
TRxADE
HEALTH, INC.
|
|
|
|
Date:
July 21, 2021
|
By:
|
/s/
Suren Ajjarapu
|
|
Name:
|
Suren
Ajjarapu
|
|
Title:
|
Chief
Executive Officer
|
TRxADE HEALTH (NASDAQ:MEDS)
Historical Stock Chart
From Mar 2024 to Apr 2024
TRxADE HEALTH (NASDAQ:MEDS)
Historical Stock Chart
From Apr 2023 to Apr 2024